Gene · 4209
MEF2D: myocyte enhancer factor 2D
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MEF2D: myocyte enhancer factor 2D. Genes, record 4209. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4209
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q14814 | Myocyte-specific enhancer factor 2D | 521 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents52
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 54531 | Q14814 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2777 | Q14814 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 345 | Q14814 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2345 | Q14814 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15278 | Q14814 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 345 | Q14814 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2345 | Q14814 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2777 | Q14814 | Espacenet |
| JP 2025513058 A | 2025-04-22 | 4 | Q14814 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15278 | Q14814 | Espacenet |
1 to 10 of 52
See all 52 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,131
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MEF2D papers | Newest fiscal year |
|---|---|---|---|
| P30CA021765 | Cancer Center Support Grant (CCSG) | 22 | 2025 |
| R35CA197695 | Translating genomic discoveries to improved outcomes for high risk acute leukemia | 13 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| U10CA180886 | COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement | 7 | 2025 |
| U10CA180899 | Children's Oncology Group Statistics and Data Center | 7 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| U24CA196172 | ECOG-ACRIN Biospecimen Bank to Support NCTN | 4 | 2025 |
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 3 | 2025 |
| P30CA014599 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,131Source NIH's project files
See all 1,131 nih grantsPapers1,497
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy. | JCO Glob Oncol | 2026 | 42691457 | PubTator, text mining | PubMed |
| The Diverse Roles of the MEF2 Transcription Factor Family in Tumor Progression and Emerging Therapeutic Opportunities. | Biomedicines | 2026 | 42652074 | PubTator, text mining | PubMed |
| A synthetic hydrogel scaffold enhancing stem cell signatures in colorectal cancer cells. | Biochem Biophys Res Commun | 2026 | 42537436 | PubTator, text mining | PubMed |
| [Clinical analysis of 9 children of B-cell acute lymphoblastic leukemia with MEF2D gene rearrangement]. | Zhonghua Er Ke Za Zhi | 2026 | 42527140 | PubTator, text mining | PubMed |
| The role of miRNA-32 in non-small cell lung cancer. | Medicine (Baltimore) | 2026 | 42432883 | PubTator, text mining | PubMed |
| Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report. | Front Oncol | 2026 | 42294267 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis identifies endocrine-disrupting chemical-related molecular mechanisms in migraine. | J Headache Pain | 2026 | 42260332 | PubTator, text mining | PubMed |
| Histone Deacetylase 7 protects against pathologic cardiac hypertrophy. | J Mol Cell Cardiol | 2026 | 42250622 | PubTator, text mining | PubMed |
| Overexpression of IGF2 Alters the Transcriptional Profile of Goose Skeletal Muscle Satellite Cells. | Biomolecules | 2026 | 42072686 | PubTator, text mining | PubMed |
| Genomic fusion breakpoints for DNA-based measurable residual disease monitoring in pediatric acute lymphoblastic leukemia. | Leukemia | 2026 | 42014859 | PubTator, text mining | PubMed |
1 to 10 of 1,497
See all 1,497 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4209
GET https://conductscience.org/api/genes/v1/4209/patents?page=2